Myeloablative radioimmunotherapy with re-188-labeled anti-cd66a,b,c,e-antibody for conditioning of high-risk all and cml patients prior to stem cell transplantation

Inga Buchmann*, Sven N. Reske, Joerg Kotzerke, Hans Martin, Gerhard Glatting, Ulrike Seitz, Dirk Rattat, Markus Wiesneth, Dagraar Dohr, Andreas Bück, Lothar Bergmann, Hartmut Doehner, Stefanie Von Harsdorf, Martin Stefanie, Christian Duncker, Donald Bunjes

*Corresponding author for this work
1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Myeloablative radioimmunotherapy with re-188-labeled anti-cd66a,b,c,e-antibody for conditioning of high-risk all and cml patients prior to stem cell transplantation'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science